Enjoy the benefits of Omega 3-6-9 essential fatty acids all from vegetable sources - Coconut and Flaxseed Oils! This formulation promotes healthy immune and heart systems, cholesterol levels, hair, and skin; and may reduce the risk of coronary heart disease. Get your own Coconut/Flaxseed Oil today!
MannKind Corp. on Tuesday announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the Food and Drug Administration voted 13-to-1 to recommend that Afrezza (insulin human [rDNA origin]) inhalation powder be granted marketing approval by the FDA to improve glycemic control in adults with Type 1 diabetes and voted 14-to-0 to recommend that Afrezza be granted marketing approval by the FDA to improve glycemic control in adults with Type 2 diabetes.
New research from Wake Forest Baptist Medical Center suggests that physicians are ordering vitamin D deficiency screening tests for preventive care purposes rather than after patients develop conditions caused by decreased bone density.
In a study that included nearly 300,000 adults without a known history of diabetes or cardiovascular disease, adding information about glycated hemoglobin (HbA1c), a measure of longer-term blood sugar control, to conventional CVD risk factors like smoking and cholesterol was associated with little improvement in the prediction of CVD risk, according to a study in the March 26 issue of JAMA.
Skinnygirl brand has already made its foray into several categories, including a recent line of water flavor enhancers and a partnership with SodaStream to create new flavors. Now the brand will step into the supplement category with its new Skinnygirl Supplements.
A new study published in the March 18 journal Annals of Internal Medicine raises questions about current guidelines which generally restrict the consumption of saturated fats and encourage consumption of polyunsaturated fats, or fish oils, to prevent heart disease.
Brigham and Women's Hospital, Seattle-based Fred Hutchinson Cancer Research Center, the National Institutes of Health and Mars, Inc. plan to partner on the largest research trial to date that will investigate the heart-health benefits of cocoa flavanols and multivitamins, the groups announced Monday.
An educational briefing, “Widespread Nutrient Shortfalls: A Public Health Crisis?” was held for Capitol Hill staffers Friday by the Congressional Dietary Supplement Caucus, in cooperation with the leading trade associations representing the dietary supplement industry — the American Herbal Products Association, the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the Natural Products Association and the United Natural Products Alliance.
Men and women with large waist circumferences — even those with a healthy body mass index — are more likely to die younger, and were more likely to die from such illnesses as heart disease, respiratory problems and cancer after accounting for BMI, smoking, alcohol use and physical activity, according to a study led by a Mayo Clinic researcher.
A study published online Friday shows that the omega-3 fatty acids EPA and DHA — commonly found in fatty fish and fish oil supplements — are as effective, if not more effective, in lowering blood pressure as some of the commonly recommended lifestyle changes like increasing physical activity and restricting alcohol and sodium intake.
Scientists from the Council for Responsible Nutrition addressed a key group of healthcare practitioners regarding recent studies on multivitamin and multimineral supplements in the Annals of Internal Medicine through a review published in the Natural Medicine Journal, the journal of the American Association of Naturopathic Physicians.
La Fresh Group, maker of portable Travel Lite and Eco-Beauty wet wipes, has announced the launch of Eco-Beauty Be Good., a line of skin care products made with a natural anti-aging botanical complex of maqui berry, licorice root, ginkgo leaf, grape seed and hickory bark.
An international team led by researchers at the Broad Institute and Massachusetts General Hospital has identified mutations in a gene that can reduce the risk of developing Type 2 diabetes, even in people who have such risk factors as obesity and old age, the group announced Sunday.
Pfizer is recruiting for a 1,200-patient actual use study to measure whether or not patients can appropriately self-select treating high cholesterol with the statin Lipitor, the Wall Street Journal reported on Sunday.